Marvin Samson, Director at ANTARES PHARMA, INC. (ATRS), sold 56 shares at $4.50 ($252) on 2020-01-10, disclosed to the SEC on 2020-01-14.
Scheduled sale ($252) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ATRS | BUY | 2016-03-21 | $36K | — | Filing → |
| ATRS | BUY | 2014-08-12 | $50K | — | Filing → |